Treatment failure in leishmaniasis. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Skin Macrophages Spleen Th1 Cells Bone Marrow Blood Ear, External

Organisms23

Leishmania Leishmania infantum Leishmania braziliensis Leishmania donovani Psychodidae Phlebotomus Leishmania tropica Leishmania guyanensis Leishmania major Leishmania mexicana Dogs Mice, Inbred BALB C Plasmodium falciparum Mesocricetus Hyraxes Rodentia Trypanosoma brucei gambiense HIV-1 Mycoplasma genitalium Cricetinae Neisseria gonorrhoeae Mice, Inbred C57BL Life Cycle Stages

Diseases49

Leishmaniasis, Visceral Leishmaniasis, Cutaneous Leishmaniasis Leishmaniasis, Mucocutaneous Leishmaniasis, Diffuse Cutaneous Heart Failure Dog Diseases Recurrence Skin Ulcer Malaria, Falciparum HIV Infections Kidney Failure, Chronic Failure to Thrive Zoonoses Euglenozoa Infections Parasitemia Liver Failure, Acute Neglected Diseases Disease Models, Animal AIDS-Related Opportunistic Infections Coinfection Liver Failure Gonorrhea Disease Progression Multiple Organ Failure Asymptomatic Infections Insect Bites and Stings Acute Disease Chronic Disease Eyelid Diseases Hodgkin Disease Chagas Disease Trypanosomiasis Rhinophyma Hypersensitivity, Delayed Trypanosomiasis, African Facial Dermatoses Cardiac Output, Low Parasitic Diseases Pharyngeal Diseases Communicable Diseases, Emerging Heart Failure, Systolic Acute Kidney Injury Staphylococcal Infections Respiratory Insufficiency Neoplasm Recurrence, Local Leprosy, Lepromatous Granuloma Prosthesis Failure

Chemicals and Drugs67

Antiprotozoal Agents Meglumine Leishmaniasis Vaccines Antimony Antimony Sodium Gluconate Antigens, Protozoan DNA, Protozoan Antibodies, Protozoan Organometallic Compounds Paromomycin Phosphorylcholine DNA, Kinetoplast Protozoan Vaccines Amphotericin B Drug Combinations Antimalarials Sulfadoxine Pyrimethamine Protozoan Proteins Pentamidine Anti-Bacterial Agents Chloroquine Trypanocidal Agents Artemisinins Amodiaquine Fluorenes Proguanil Anti-HIV Agents Interferon-gamma Atovaquone Dihydropteroate Synthase Benzethonium Cefixime Azithromycin Antitubercular Agents Penicillin G Procaine Aminoquinolines Cytochromes b Amoxicillin Interleukin-10 Metronidazole Melarsoprol Fluoxymesterone Immunoglobulin G Anti-Infective Agents Ethanolamines Ceftriaxone Doxorubicin Cytokines Tetrahydrofolate Dehydrogenase Vincristine Interleukin-4 Insecticides Rifampin Biological Markers Recombinant Proteins Prednisone Pyrethrins Naphthoquinones Mefloquine Vancomycin Anti-Retroviral Agents Cyclophosphamide Antineoplastic Agents Interleukin-12 Sesquiterpenes Allopurinol

Analytical, Diagnostic and Therapeutic Techniques and Equipment51

Treatment Failure Treatment Outcome Parasite Load Drug Therapy, Combination Parasitic Sensitivity Tests Retrospective Studies Polymerase Chain Reaction Sensitivity and Specificity Follow-Up Studies Prospective Studies Serologic Tests Skin Tests Drug Administration Schedule Enzyme-Linked Immunosorbent Assay Agglutination Tests Risk Factors Prognosis Survival Analysis Immunochromatography Cohort Studies Administration, Oral Disease Models, Animal Incidence Drug Monitoring Microbial Sensitivity Tests Predictive Value of Tests Antineoplastic Combined Chemotherapy Protocols Antiretroviral Therapy, Highly Active Double-Blind Method Survival Rate Disease-Free Survival Intradermal Tests Fluorescent Antibody Technique, Indirect Viral Load Biopsy CD4 Lymphocyte Count Combined Modality Therapy Kaplan-Meier Estimate Severity of Illness Index Prevalence Salvage Therapy Sequence Analysis, DNA Case-Control Studies Injections, Intramuscular Equipment Failure Administration, Topical Infusions, Intravenous Clinical Trials as Topic Inhibitory Concentration 50 Prosthesis Failure Injections, Intravenous

Psychiatry and Psychology1

Patient Compliance

Phenomena and Processes19

Drug Resistance Sensitivity and Specificity Time Factors Drug Resistance, Viral Seasons Genotype Drug Resistance, Bacterial Viral Load CD4 Lymphocyte Count Polymorphism, Restriction Fragment Length Immunocompromised Host Dose-Response Relationship, Drug Host-Parasite Interactions Mutation Drug Resistance, Neoplasm Life Cycle Stages Inhibitory Concentration 50 Drug Resistance, Multiple Genes, Protozoan

Disciplines and Occupations4

Parasitology Geography, Medical Topography, Medical Tropical Medicine

Anthropology, Education, Sociology and Social Phenomena1

Technology, Industry, Agriculture1

Military Facilities

Information Science4

Incidence Survival Rate Prevalence Molecular Sequence Data

Named Groups2

Infant, Newborn Military Personnel

Health Care29

Treatment Failure Treatment Outcome Insect Vectors Endemic Diseases Disease Reservoirs Insect Control Retrospective Studies Sensitivity and Specificity Follow-Up Studies Prospective Studies Disease Vectors Risk Factors Survival Analysis Population Density Cohort Studies Incidence Predictive Value of Tests Seasons Double-Blind Method Survival Rate Disease-Free Survival Kaplan-Meier Estimate Severity of Illness Index Prevalence Case-Control Studies Rural Population Rural Health Patient Compliance Clinical Trials as Topic

Geographicals24

Brazil Sudan India Venezuela Peru Colombia Argentina Nepal Bolivia Ethiopia Panama Afghanistan Bangladesh Tunisia Iran Ecuador Suriname Kenya Uganda USSR Mediterranean Region Morocco French Guiana Asia, Central

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care Geographicals

Leishmaniasis, Visceral Leishmaniasis, Cutaneous Leishmaniasis Treatment Failure Leishmaniasis, Mucocutaneous Antiprotozoal Agents Leishmania Leishmania infantum Leishmania braziliensis Leishmania donovani Psychodidae Leishmaniasis, Diffuse Cutaneous Meglumine Leishmaniasis Vaccines Antimony Heart Failure Antimony Sodium Gluconate Phlebotomus Leishmania tropica Dog Diseases Leishmania guyanensis Leishmania major Antigens, Protozoan Leishmania mexicana DNA, Protozoan Treatment Outcome Antibodies, Protozoan Organometallic Compounds Insect Vectors Endemic Diseases Brazil Paromomycin Phosphorylcholine DNA, Kinetoplast Protozoan Vaccines Sudan Amphotericin B Drug Resistance Parasite Load Dogs Drug Combinations Antimalarials Disease Reservoirs Drug Therapy, Combination Insect Control Sulfadoxine India Venezuela Pyrimethamine Protozoan Proteins Parasitic Sensitivity Tests Pentamidine Retrospective Studies Parasitology Polymerase Chain Reaction Recurrence Skin Ulcer Malaria, Falciparum Sensitivity and Specificity Anti-Bacterial Agents Mice, Inbred BALB C Peru Time Factors Colombia Chloroquine Follow-Up Studies Prospective Studies Trypanocidal Agents Argentina HIV Infections Artemisinins Disease Vectors Serologic Tests Skin Tests Amodiaquine Drug Administration Schedule Fluorenes Nepal Enzyme-Linked Immunosorbent Assay Proguanil Kidney Failure, Chronic Skin Plasmodium falciparum Failure to Thrive Zoonoses Agglutination Tests Bolivia Anti-HIV Agents Interferon-gamma Atovaquone Risk Factors Prognosis Dihydropteroate Synthase Ethiopia Survival Analysis Benzethonium Cefixime Drug Resistance, Viral Population Density Azithromycin

No FAQ available that match "treatment failure in leishmaniasis"